These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4380587)

  • 1. Failure of beta-adrenergic blockade to alter ventricular fibrillation threshold in the dog. Evidence for extra-adrenergic effects of pronethalol.
    Rosati RA; Alexander JA; Wallace AG; Sealy WC; Young WG
    Circ Res; 1966 Oct; 19(4):721-5. PubMed ID: 4380587
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of reserpine and pronethalol on the therapeutic and toxic actions of digitalis in the dog heart-lung preparation.
    Fawaz G
    Br J Pharmacol Chemother; 1967 Mar; 29(3):302-8. PubMed ID: 4382326
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillation.
    Raeder EA; Verrier RL; Lown B
    J Am Coll Cardiol; 1983 Jun; 1(6):1442-6. PubMed ID: 6133890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of pronethalol and propranolol on the coronary circulation of the dog.
    Davis WG; MacDonald DC; Mason DF
    Br J Pharmacol; 1969 Oct; 37(2):338-56. PubMed ID: 4390667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of dichloro-isoproterenol, pronethalol and propranolol on arterial pressure of the amyelic dog and on the rate of the enervated heart].
    Duchêne-Marullaz P; Delort P; Rispat G; Cosnier D
    C R Seances Soc Biol Fil; 1966; 160(8):1600-4. PubMed ID: 4383096
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E; Lucchesi BR
    Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of beta sympathetic blockade.
    Shanks RG
    Am J Cardiol; 1966 Sep; 18(3):308-16. PubMed ID: 4380735
    [No Abstract]   [Full Text] [Related]  

  • 8. Inotropic and chronotropic effects of a series of beta-adrenergic blocking drugs: some structure-activity relationships.
    Levy JV; Richards V
    Proc Soc Exp Biol Med; 1966 Jun; 122(2):373-9. PubMed ID: 4382783
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
    Baum T; Peters JR; Eckfeld DK; Varner LL; Dinish J; Metz N; Shropshire AT
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of yohimbine, phentolamine, D.C.I., pronethalol and propranolol on cardic frequency of the dog].
    Duchêne-Marullaz P; Schaff G; Delort P; Billaud J
    Therapie; 1967; 22(6):1377-90. PubMed ID: 4385115
    [No Abstract]   [Full Text] [Related]  

  • 12. Tyramine-induced modifications of ventricular fibrillation thresholds in the dog: influence of sympatholytic agents.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):253-61. PubMed ID: 4125092
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of beta-adrenergic receptor blockade on the blood pressure and heart rate changes induced by noradrenaline infusion and postinfusional hypotension.
    Mazurkiewicz IM
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):136-58. PubMed ID: 4384633
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog.
    Davis LD; Temte JV
    Circ Res; 1968 May; 22(5):661-77. PubMed ID: 5648068
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of adrenergic neuron blocking effects of propranolol & pronethalol.
    Ganguly DK; Bhattacharya BB
    Indian J Exp Biol; 1973 Mar; 11(2):95-100. PubMed ID: 4150101
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity.
    Houle MS; Billman GE
    Am J Physiol; 1999 Jan; 276(1):H215-23. PubMed ID: 9887035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflections on beta-adrenergic blockade in anaesthetics.
    Johnstone M
    Br J Anaesth; 1970 Mar; 42(3):262-8. PubMed ID: 4393293
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular fibrillation threshold; its physiological and pharmacological importance.
    Moore EN; Spear JF
    Arch Intern Med; 1975 Mar; 135(3):446-53. PubMed ID: 1130920
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the actions of alprenolol and propranolol on the beta adrenergic receptors controlling heart rate in the anaesthetized cat.
    Ablad B; Brändström A; Ek L; Sjölander M
    Eur J Pharmacol; 1971 May; 14(4):319-32. PubMed ID: 4400533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.